BAX
Price
$30.59
Change
+$0.60 (+2.00%)
Updated
Jun 24 closing price
Capitalization
21.77B
29 days until earnings call
HOLX
Price
$64.83
Change
+$0.40 (+0.62%)
Updated
Jun 24 closing price
Capitalization
17.87B
28 days until earnings call
Interact to see
Advertisement

BAX vs HOLX

Header iconBAX vs HOLX Comparison
Open Charts BAX vs HOLXBanner chart's image
Baxter International
Price$30.59
Change+$0.60 (+2.00%)
Volume$3.91M
Capitalization21.77B
Hologic
Price$64.83
Change+$0.40 (+0.62%)
Volume$2.24M
Capitalization17.87B
BAX vs HOLX Comparison Chart in %
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. HOLX commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Hold and HOLX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (BAX: $29.99 vs. HOLX: $64.43)
Brand notoriety: BAX and HOLX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BAX: 83% vs. HOLX: 85%
Market capitalization -- BAX: $21.77B vs. HOLX: $17.87B
BAX [@Medical Specialties] is valued at $21.77B. HOLX’s [@Medical Specialties] market capitalization is $17.87B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 2 FA rating(s) are green whileHOLX’s FA Score has 0 green FA rating(s).

  • BAX’s FA Score: 2 green, 3 red.
  • HOLX’s FA Score: 0 green, 5 red.
According to our system of comparison, BAX is a better buy in the long-term than HOLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 3 TA indicator(s) are bullish while HOLX’s TA Score has 5 bullish TA indicator(s).

  • BAX’s TA Score: 3 bullish, 6 bearish.
  • HOLX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HOLX is a better buy in the short-term than BAX.

Price Growth

BAX (@Medical Specialties) experienced а -2.69% price change this week, while HOLX (@Medical Specialties) price change was -1.15% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.18%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was -0.38%.

Reported Earning Dates

BAX is expected to report earnings on Jul 24, 2025.

HOLX is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Medical Specialties (+1.18% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAX($21.8B) has a higher market cap than HOLX($17.9B). BAX has higher P/E ratio than HOLX: BAX (85.61) vs HOLX (36.08). BAX YTD gains are higher at: 3.922 vs. HOLX (-10.626). BAX has higher annual earnings (EBITDA): 1.67B vs. HOLX (1.06B). BAX has more cash in the bank: 3.19B vs. HOLX (1.93B). HOLX has less debt than BAX: HOLX (2.58B) vs BAX (14.4B). BAX has higher revenues than HOLX: BAX (14.8B) vs HOLX (3.97B).
BAXHOLXBAX / HOLX
Capitalization21.8B17.9B122%
EBITDA1.67B1.06B157%
Gain YTD3.922-10.626-37%
P/E Ratio85.6136.08237%
Revenue14.8B3.97B373%
Total Cash3.19B1.93B165%
Total Debt14.4B2.58B559%
FUNDAMENTALS RATINGS
BAX vs HOLX: Fundamental Ratings
BAX
HOLX
OUTLOOK RATING
1..100
6815
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
9262
PRICE GROWTH RATING
1..100
5948
P/E GROWTH RATING
1..100
1383
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (9) in the Medical Specialties industry is somewhat better than the same rating for HOLX (73). This means that BAX’s stock grew somewhat faster than HOLX’s over the last 12 months.

HOLX's Profit vs Risk Rating (69) in the Medical Specialties industry is in the same range as BAX (100). This means that HOLX’s stock grew similarly to BAX’s over the last 12 months.

HOLX's SMR Rating (62) in the Medical Specialties industry is in the same range as BAX (92). This means that HOLX’s stock grew similarly to BAX’s over the last 12 months.

HOLX's Price Growth Rating (48) in the Medical Specialties industry is in the same range as BAX (59). This means that HOLX’s stock grew similarly to BAX’s over the last 12 months.

BAX's P/E Growth Rating (13) in the Medical Specialties industry is significantly better than the same rating for HOLX (83). This means that BAX’s stock grew significantly faster than HOLX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXHOLX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
54%
MACD
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
55%
Advances
ODDS (%)
Bullish Trend 15 days ago
52%
Bullish Trend 15 days ago
52%
Declines
ODDS (%)
Bearish Trend 7 days ago
58%
Bearish Trend 7 days ago
54%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
55%
Aroon
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEB2850.6328.63
+1.01%
Seaboard Corp
NXGL2.36N/A
N/A
NexGel
FSLR144.67-0.33
-0.23%
First Solar
QURE13.95-0.26
-1.83%
uniQure NV
HNRG15.03-0.29
-1.89%
Hallador Energy Company

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been loosely correlated with A. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
N/A
A - BAX
54%
Loosely correlated
+0.49%
RVTY - BAX
53%
Loosely correlated
-0.04%
MTD - BAX
52%
Loosely correlated
+0.84%
SYK - BAX
51%
Loosely correlated
+0.98%
STE - BAX
50%
Loosely correlated
+0.53%
More

HOLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOLX has been loosely correlated with ZBH. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if HOLX jumps, then ZBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOLX
1D Price
Change %
HOLX100%
-0.08%
ZBH - HOLX
43%
Loosely correlated
+0.62%
BDX - HOLX
41%
Loosely correlated
+0.77%
RVTY - HOLX
40%
Loosely correlated
-0.04%
BAX - HOLX
39%
Loosely correlated
N/A
QGEN - HOLX
39%
Loosely correlated
+0.34%
More